Skip to main content

KINASA LIGADA A INTEGRINAS: POSIBLE BIOMARCADOR DE PROGRESION DE LA ENFERMEDAD RENAL CRONICA (ERC) Y MODULADOR DE LA DISFUNCION MONOCITARIA RESPONSABLE DEL DAÑO CARDIOVASCULAR

PI17/01513

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2017
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INVESTIGACION BIOMEDICA HOSP. PRINCIPE DE ASTURIAS
Execution centre HOSPITAL PRINCIPE DE ASTURIAS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Indoxyl sulfate- and P-cresol-induced monocyte adhesion and migration is mediated by integrin-linked kinase-dependent podosome formation

  • Campillo, Sofía
  • Bohorquez, Lourdes
  • Gutiérrez-Calabrés, Elena
  • García-Ayuso, Diego
  • Frutos, Sergio de
  • Rodríguez-Puyol, Manuel
  • Rodríguez-Puyol, Diego
  • Calleros, Laura
Cardiovascular disease is an important cause of death in patients with chronic kidney disease (CKD). Protein-bound uremic toxins, such as p-cresyl and indoxyl sulfate (IS), are poorly removed during hemodialysis, leading to vascular endothelial dysfunction and leukocyte extravasation. These processes can be related to dynamic adhesion structures called podosomes. Several studies have indicated the role of integrin-linked kinase (ILK) in the accumulation of integrin-associated proteins in podosomes. Here, we investigated the involvement of ILK and podosome formation in the adhesion and extravasation of monocytes under p-cresol (pc) and IS exposure. Incubation of THP-1 human monocyte cells with these toxins upregulated ILK kinase activity. Together, both toxins increased cell adhesion, podosome formation, extracellular matrix degradation, and migration of THP-1 cells, whereas ILK depletion with specific small interfering RNAs suppressed these processes. Interestingly, F-actin colocalized with cortactin in podosome cores, while ILK was colocalized in podosome rings under toxin stimulation. Podosome Wiskott-Aldrich syndrome protein (WASP)-interacting protein (WIP) and AKT protein depletion demonstrated that monocyte adhesion depends on podosome formation and that the ILK/AKT signaling pathway is involved in these processes. Ex vivo experiments showed that both toxins induced adhesion and podosome formation in leukocytes from wild-type mice, whereas these effects were not observed in leukocytes of conditional ILK-knockdown animals. In summary, under pc and IS stimulation, monocytes increase podosome formation and transmigratory capacity through an ILK/AKT signaling pathway-dependent mechanism, which could lead to vascular injury. Therefore, ILK could be a potential therapeutic target for the treatment of vascular damage associated with CKD., This work was supported by co-funded grants from the Instituto de Salud Carlos III (ISCIII) and FEDER funds (PI17/01513, PI17/00625, PI20/00634, PI20/00664, RETIC REDinREN program RD16/0009/0018), Madrid Community funds (B2017/BMD-3751), and University of Alcalá and FRIAT funds.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Graphene-Based Bioactive Product with a Non-Immunological Impact on Mononuclear Cell Populations from Healthy Volunteers

  • Lavín-López, María del Prado
  • Torres-Torresano, Mónica
  • García-Cuesta, Eva María
  • Soler Palacios, Blanca
  • Griera, Mercedes
  • Martínez-Rovira, Martín
  • Martínez-Rovira, José Antonio
  • Rodríguez-Puyol, Diego
  • Frutos, Sergio de
We previously described GMC, a graphene-based nanomaterial obtained from carbon nanofibers (CNFs), to be biologically compatible and functional for therapeutic purposes. GMC can reduce triglycerides’ content in vitro and in vivo and has other potential bio-functional effects on systemic cells and the potential utility to be used in living systems. Here, immunoreactivity was evaluated by adding GMC in suspension at the biologically functional concentrations, ranging from 10 to 60 µg/mL, for one or several days, to cultured lymphocytes (T, B, NK), either in basal or under stimulating conditions, and monocytes that were derived under culture conditions to pro-inflammatory (GM-MØ) or anti-inflammatory (M-MØ) macrophages. All stirpes were obtained from human peripheral mononuclear cells (PBMCs) from anonymized healthy donors. The viability (necrosis, apoptosis) and immunological activity of each progeny was analyzed using either flow cytometry and/or other analytical determinations. A concentration of 10 to 60 µg/mL GMC did not affect lymphocytes’ viability, either in basal or active conditions, during one or more days of treatment. The viability and expression of the inflammatory interleukin IL-1β in the monocyte cell line THP-1 were not affected. Treatments with 10 or 20 µg/mL GMC on GM-MØ or M-MØ during or after their differentiation process promoted phagocytosis, but their viability and the release of the inflammatory marker activin A by GM-MØ were not affected. A concentration of 60 µg/mL GMC slightly increased macrophages’ death and activity in some culture conditions. The present work demonstrates that GMC is safe or has minimal immunological activity when used in suspension at low concentrations for pre-clinical or clinical settings. Its biocompatibility will depend on the dose, formulation or way of administration and opens up the possibility to consider GMC or other CNF-based biomaterials for innovative therapeutic strategies., This work was supported partially by co-funded grants from the Instituto de Salud Carlos III (ISCIII), Comunidad de Madrid, Universidad de Alcala and FEDER funds: PI17/01513, PI17/00625, PI20/00634, PI23/01071, P2022/BMD7221 and B2017/BMD3751; the RETIC REDinREN and RICORS 2040 programs (RD16/0009/0018; RD21/0005/0023; RD24/0004/0020); INNOREN-CM and NOVELREN-CM; PIUAH23/CCS-010; and art.60 LOSU 2022/024. GMC sponsored part of this research financially through the acquisition of reagents and small laboratory equipment., Peer reviewed